Based on preclinical work, the transient increase in eosinophils observed in asthma and CRSwNP patients may be related to blockade of IL‐4Rα with dupilumab reducing eotaxin production, thus inhibiting eosinophil chemotaxis and tissue infiltration.15 Here, IL4R is linked to chronic rhinosinusitis with nasal polyps.